Tuesday, August 18, 2009

Amgen's Vectibix Meets Goal In Colon Cancer Study - Visit Bulgaria


Visit Bulgaria

Amgen's Vectibix Meets Goal In Colon person Study
Visit Bulgaria
... from the studies module be presented at an upcoming medical conference in Europe, feat Amgen shares to rise 5-cents to $59.89 in after-hours trading.

and more »

No comments:

Post a Comment